Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma

Jiaze Tang,1 Ning Huang,1 Xiang Zhang,1,2 Tao Zhou,3 Ying Tan,1,4 Jiangli Pi,5 Li Pi,1 Si Cheng,6 Huzhi Zheng,5 Yuan Cheng1 1Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, 2Chongqing Key Laboratory of Ultrasound Molecular Imaging, Institute of Ultrasound...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tang J, Huang N, Zhang X, Zhou T, Tan Y, Pi J, Pi L, Cheng S, Zheng H, Cheng Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/32acfd2843144c13a35b6fbbc614a2cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32acfd2843144c13a35b6fbbc614a2cf
record_format dspace
spelling oai:doaj.org-article:32acfd2843144c13a35b6fbbc614a2cf2021-12-02T07:43:59ZAptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma1178-2013https://doaj.org/article/32acfd2843144c13a35b6fbbc614a2cf2017-05-01T00:00:00Zhttps://www.dovepress.com/aptamer-conjugated-pegylated-quantum-dots-targeting-epidermal-growth-f-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Jiaze Tang,1 Ning Huang,1 Xiang Zhang,1,2 Tao Zhou,3 Ying Tan,1,4 Jiangli Pi,5 Li Pi,1 Si Cheng,6 Huzhi Zheng,5 Yuan Cheng1 1Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, 2Chongqing Key Laboratory of Ultrasound Molecular Imaging, Institute of Ultrasound Imaging, 3Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, 4Institute of Life Sciences, Chongqing Medical University, 5Key Laboratory on Luminescent and Real-Time Analytical Chemistry, Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, 6Department of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China Abstract: The extent of resection is a significant prognostic factor in glioma patients. However, the maximum safe resection level is difficult to determine due to the inherent infiltrative character of tumors. Recently, fluorescence-guided surgery has emerged as a new technique that allows safe resection of glioma. In this study, we constructed a new kind of quantum dot (QD)-labeled aptamer (QD-Apt) nanoprobe by conjugating aptamer 32 (A32) to the QDs surface, which can specially bind to the tumors. A32 is a single-stranded DNA capable of binding to the epidermal growth factor receptor variant III (EGFRvIII) specially distributed on the surface of glioma cells. To detect the expression of EGFRvIII in human brain tissues, 120 specimens, including 110 glioma tissues and 10 normal brain tissues, were examined by immunohistochemistry, and the results showed that the rate of positive expression of EGFRvIII in the glioma tissues was 41.82%, and 0.00% in normal brain tissues. Besides, the physiochemical properties of QD-Apt nanoparticles (NPs) were thoroughly characterized. Biocompatibility of the NPs was evaluated, and the results suggested that the QD-Apt was nontoxic in vivo and vitro. Furthermore, the use of the QD-Apt in labeling glioma cell lines and human brain glioma tissues, and target gliomas in situ was also investigated. We found that not only could QD-Apt specially bind to the U87-EGFRvIII glioma cells but also bind to human glioma tissues in vitro. Fluorescence imaging in vivo with orthotopic glioma model mice bearing U87-EGFRvIII showed that QD-Apt could penetrate the blood–brain barrier and then selectively accumulate in the tumors through binding to EGFRvIII, and consequently, generate a strong fluorescence, which contributed to the margins of gliomas that were visualized clearly, and thus, help the surgeons realize the maximum safe resection of glioma. In addition, QD-Apt can also be applied in preoperative diagnosis and postoperative examination of glioma. Therefore, these achievements facilitate the use of tumor-targeted fluorescence imaging in the diagnosis, surgical resection, and postoperative examination of glioma. Keywords: quantum dot, aptamer, EGFRvIII, brain glioma, tumor-targeted imaging, extent of resection Tang JHuang NZhang XZhou TTan YPi JPi LCheng SZheng HCheng YDove Medical PressarticleQuantum dotAptamerEGFRvIIIBrain gliomatumor-targeted imagingextent of resection (EOR)Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 3899-3911 (2017)
institution DOAJ
collection DOAJ
language EN
topic Quantum dot
Aptamer
EGFRvIII
Brain glioma
tumor-targeted imaging
extent of resection (EOR)
Medicine (General)
R5-920
spellingShingle Quantum dot
Aptamer
EGFRvIII
Brain glioma
tumor-targeted imaging
extent of resection (EOR)
Medicine (General)
R5-920
Tang J
Huang N
Zhang X
Zhou T
Tan Y
Pi J
Pi L
Cheng S
Zheng H
Cheng Y
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
description Jiaze Tang,1 Ning Huang,1 Xiang Zhang,1,2 Tao Zhou,3 Ying Tan,1,4 Jiangli Pi,5 Li Pi,1 Si Cheng,6 Huzhi Zheng,5 Yuan Cheng1 1Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, 2Chongqing Key Laboratory of Ultrasound Molecular Imaging, Institute of Ultrasound Imaging, 3Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, 4Institute of Life Sciences, Chongqing Medical University, 5Key Laboratory on Luminescent and Real-Time Analytical Chemistry, Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, 6Department of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China Abstract: The extent of resection is a significant prognostic factor in glioma patients. However, the maximum safe resection level is difficult to determine due to the inherent infiltrative character of tumors. Recently, fluorescence-guided surgery has emerged as a new technique that allows safe resection of glioma. In this study, we constructed a new kind of quantum dot (QD)-labeled aptamer (QD-Apt) nanoprobe by conjugating aptamer 32 (A32) to the QDs surface, which can specially bind to the tumors. A32 is a single-stranded DNA capable of binding to the epidermal growth factor receptor variant III (EGFRvIII) specially distributed on the surface of glioma cells. To detect the expression of EGFRvIII in human brain tissues, 120 specimens, including 110 glioma tissues and 10 normal brain tissues, were examined by immunohistochemistry, and the results showed that the rate of positive expression of EGFRvIII in the glioma tissues was 41.82%, and 0.00% in normal brain tissues. Besides, the physiochemical properties of QD-Apt nanoparticles (NPs) were thoroughly characterized. Biocompatibility of the NPs was evaluated, and the results suggested that the QD-Apt was nontoxic in vivo and vitro. Furthermore, the use of the QD-Apt in labeling glioma cell lines and human brain glioma tissues, and target gliomas in situ was also investigated. We found that not only could QD-Apt specially bind to the U87-EGFRvIII glioma cells but also bind to human glioma tissues in vitro. Fluorescence imaging in vivo with orthotopic glioma model mice bearing U87-EGFRvIII showed that QD-Apt could penetrate the blood–brain barrier and then selectively accumulate in the tumors through binding to EGFRvIII, and consequently, generate a strong fluorescence, which contributed to the margins of gliomas that were visualized clearly, and thus, help the surgeons realize the maximum safe resection of glioma. In addition, QD-Apt can also be applied in preoperative diagnosis and postoperative examination of glioma. Therefore, these achievements facilitate the use of tumor-targeted fluorescence imaging in the diagnosis, surgical resection, and postoperative examination of glioma. Keywords: quantum dot, aptamer, EGFRvIII, brain glioma, tumor-targeted imaging, extent of resection 
format article
author Tang J
Huang N
Zhang X
Zhou T
Tan Y
Pi J
Pi L
Cheng S
Zheng H
Cheng Y
author_facet Tang J
Huang N
Zhang X
Zhou T
Tan Y
Pi J
Pi L
Cheng S
Zheng H
Cheng Y
author_sort Tang J
title Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
title_short Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
title_full Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
title_fullStr Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
title_full_unstemmed Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
title_sort aptamer-conjugated pegylated quantum dots targeting epidermal growth factor receptor variant iii for fluorescence imaging of glioma
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/32acfd2843144c13a35b6fbbc614a2cf
work_keys_str_mv AT tangj aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT huangn aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT zhangx aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT zhout aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT tany aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT pij aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT pil aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT chengs aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT zhengh aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
AT chengy aptamerconjugatedpegylatedquantumdotstargetingepidermalgrowthfactorreceptorvariantiiiforfluorescenceimagingofglioma
_version_ 1718399211911774208